Smith Anglin Financial, LLC
- SEC CIK
- 0001553540
- Latest filing
- Jul 17, 2025
AMRX holding history
Amneal Pharmaceuticals, Inc. in every 13F filed by Smith Anglin Financial, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMRX overviewAll 13F holders of AMRXFull Q2 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −29,050−100.0% | Sold out | Holders |
| Q1 2025 | 29,050 | $243.4K | <0.1% | +50+0.2% | Added | Holders |
| Q4 2024 | 29,000 | $229.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 29,000 | $241.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 29,000 | $184.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 29,000 | $175.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 29,000 | $176.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 29,000 | $122.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 29,000 | $89.9K | <0.1% | −1,300−4.3% | Reduced | Holders |
| Q1 2023 | 30,300 | $42.1K | <0.1% | +30,300 | New | Holders |